We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

New Minimally Invasive Cancer Diagnostic Device Eavesdrops On Cells’ Conversations

By LabMedica International staff writers
Posted on 26 Oct 2023
Print article
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)

For a long time, scientists have understood that RNA (ribonucleic acid) serves as an internal messenger within cells, taking DNA's instructions to help the cells produce proteins. However, a recent discovery shows that specific kinds of RNA, termed "extracellular RNA" or exRNA, actually leave the cell. These exRNAs are enclosed in tiny carrier structures and travel through bodily fluids, acting like tiny informational messages in bottles. These exRNAs are incredibly valuable as they could hold early indicators for diseases like cancer, heart disease, and HIV. Detecting diseases via exRNA could be quicker, more effective, and cheaper than current techniques. The challenge, however, has been separating and interpreting these exRNAs, as existing methods like advanced filters and centrifuges haven't been very successful.

A team of scientists at the University of Notre Dame (Notre Dame, IN, USA) has created a groundbreaking device that uses an ingenious approach to 'eavesdrop' on cells’ conversations. This palm-sized device combines existing technologies and employs a mix of pH levels and electrical charges to segregate the exRNA carriers. The unique feature here is that each type of carrier has its own "isoelectric point," a particular pH level at which it has no positive or negative charge. Within the device, there's a seemingly simple stream of water flowing. But this stream is special. On the left side, the water is highly acidic, similar to grapefruit juice. On the opposite end of the stream, the water is extremely basic, with a pH similar to a bottle of ammonia. What's particularly remarkable about the device is its ability to generate this pH gradient in the stream without adding any chemicals, making it cost-effective and eco-friendly.

This gradient is made possible by a two-sided membrane that's powered by a custom-designed chip. This membrane divides the water into two types of ions: acidic hydronium ions and basic hydroxide ions, adding a different kind of ion to each side of the stream. As these acidic and basic streams converge, they form a pH gradient, much like how hot and cold streams form hot and cold sides with a gradient of temperature through the middle of the stream. The researchers ran the two devices in parallel and utilized machine learning to select the ideal pH range needed for separating the carriers.

What sets this approach apart is its effectiveness of the pH gradient in segregating the exRNA carriers floating in the stream. When they pass through the pH gradient, the different types of carriers form lines along their isoelectric points, making it easy to channel them into separate outlets. The researchers could obtain incredibly pure samples—up to 97%—using less than a milliliter of body fluids like blood plasma, saliva, or urine. Moreover, while the best current technologies take around a day to separate samples, this new device accomplished the task in just 30 minutes.

“Noncommunicable diseases are responsible for more than 70 percent of deaths worldwide, and cardiovascular disease and cancer are responsible for most of that number,” said postdoctoral fellow Himani Sharma who served as project lead. “Our technology shows a path to improving the way clinicians diagnose these diseases, and that could save a tremendous number of lives.”

Related Links:
University of Notre Dame

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Dengue Virus Test

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.